Skip to content

Author

N. Peragine

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Dynamics of in vivo immune remodeling in Ph+ all patients receiving frontline ponatinib and blinatumomab therapy

: Tyrosine kinase inhibitor (TKI)-based chemotherapy-free strategies, combining dasatinib or ponatinib with the bispeci fi c monoclonal antibody blinatumomab, have substantially improved the response rates and outcome of adult patients with Philadel-phia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) [1 – 7]...

N. Peragine, M. Ansuinelli, G. Radice et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.